New Illinois bill would allow mothers paid breaks to breastfeed
The , sponsored by Illinois Senator Laura Fine (D-Glenview), were first read in Illinois' General Assembly on January 22nd.
The Nursing Mothers in the Workplace Act would be changed to require employers to provide 30 minutes of paid breaks to mothers who need to breastfeed or pump.
'When you're a new mom and you're tired, you're emotional and you're getting back to work, for me we did not have that break to take care of my child,' Fine said.
These required breaks would not cut into any other required breaks.
Fine explained she wants to look out for succeeding generations by implementing these new requirements.
'We want to make [it] easier and smoother for future generations,' said Fine. 'Women causes are front and center cause we're saying that this is what impacted us, how can we improve it for future generations.'
Senator Doris Turner (D-Springfield) stands with Fine on these issues and has sponsored a of her own to introduce a plan to cover hypoallergenic formula under Medicaid if it has been prescribed by a physician.
'You can imagine the strain that would put on your budget,' Turner said. 'We are ensuring that families get a fair chance at a healthy life regardless of their income.'
Both bills have been sent to committee and could be deliberated later in February.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


UPI
an hour ago
- UPI
Wisconsin Lt. Gov. Sara Rodriguez launches gubernatorial bid
Wisconsin Lt. Gov. Sara Rodriguez is running for governor, the former emergency room nurse confirmed Friday. Photo courtesy of Governor of Wisconsin's office July 25 (UPI) -- Wisconsin Lt. Gov. Sara Rodriguez is running for governor, the former emergency room nurse confirmed Friday. "I'm used to being on my feet and getting right to the point, so let's go. First, I have an announcement. I'm running for governor," Rodriguez announced in a video released Friday, her 50th birthday. Rodriguez joins the Democratic primary field to replace Gov. Tony Evers, D-Wis. Evers, 73, announced in a video Thursday he would not seek re-election in November when he will turn 74. Evers has been the Governor of Wisconsin for six years and in public service for 50 years. Rodriguez is the first big name to enter the race to replace Evers. Milwaukee County Executive David Crowley confirmed Thursday to Spectrum News 1 Wisconsin that he plans to run. Former Wisconsin Lt. Gov. Mandela Barnes posted a photo of himself with Evers on X Thursday, thanking him for his service. Barnes served as lieutenant governor during Evers' first term and has hinted at a run for the office. Rodriguez previously worked in the emergency department of Baltimore's Mercy Medical Center. She later took a job at the U.S. Centers for Disease Control and Prevention between 2004 and 2006 before returning to Wisconsin. Increasing salaries for public teachers and expanding Medicaid access are among the promises Rodriguez makes in the video. "Look, we've got a real shot at flipping the state Legislature and with a Democratic governor, we can finally expand Medicaid and boost our healthcare workforce," Rodriguez says in the video, that also touches on her family's working-class roots in Wisconsin. "With a Democratic governor, we can finally expand Medicaid and boost our healthcare workforce, strengthen our farms, unions, and small businesses, fund our public schools and give teachers the raise they've earned. That's the right path."


Time Magazine
2 hours ago
- Time Magazine
The ‘Big Beautiful Bill' May Lead to More Fatal Overdoses
The sweeping tax and spending package that President Donald Trump signed into law earlier this month could cause thousands of people to lose access to treatment for opioid use disorder, leading to roughly 1,000 additional overdose deaths each year, researchers estimate. Fatal overdoses have been on the decline since they reached a record high in 2022. Drug policy and health experts have widely credited the drop to public health measures, such as investing in treatments, expanding therapies, and decreasing stigma. But now, they fear that Trump's 'Big Beautiful Bill' will undo that progress. The day before the bill passed the House, a group of researchers sent a memo to House Speaker Mike Johnson and Senate Majority Leader John Thune, estimating that the package would cause about 156,000 people to lose access to treatment for opioid use disorder. The next day, the bill cleared the House, and the day after, Trump signed it into law. 'I'm angry,' says Dr. Benjamin Linas, the lead researcher behind the memo and a professor of medicine and epidemiology at Boston University. 'I think it's a terrible policy. I think it's doing nothing but making America unhealthy and increasing misery.' The bill's provisions targeting Medicaid are expected to leave about 7.8 million people without health insurance in 2034 due to loss of coverage under the program, according to the Congressional Budget Office. Using that estimate, Linas and his colleagues projected, based on previous data about the proportion of people on Medicaid who receive medications for opioid use disorder, how many of those people will likely lose access to treatments. They then used simulation modeling to estimate how many additional fatal overdoses would occur in one year. Linas called the findings 'upsetting,' adding that the 1,000 additional deaths researchers projected was likely an underestimate because he and his colleagues only accounted for people not being able to access their medications for opioid use disorder—not for any other health complications that could worsen after losing access to health insurance, such as infections, heart attack, or cancer. Researchers also didn't account for the possibility that Medicaid cuts could cause some people to lose access to their preferred medication, forcing them to use a different option, which could cause 'misery and suffering and death,' Linas says. 'It's well-known and documented that when people can't get the treatment that's effective for them or that they would choose, the treatments are less effective and they fall out of care,' Linas says. American Society of Addiction Medicine (ASAM) President Dr. Stephen Taylor, who was not involved in writing the memo, says that while the impacts of the bill will vary from state to state, he found the researchers' findings to be reasonable. He notes that the bill has some provisions for people with substance use disorder, including exempting them from work requirements. 'Our focus at ASAM is just to try to mitigate some of the harms from the bill [and] make sure that these exemptions … will be implemented in as expansive and as generous a way as possible,' Taylor says. 'We want to prevent people from losing the coverage that they need; otherwise, those exemptions will be meaningless.' But Linas also points out that many people who are struggling with addiction are not diagnosed, which could make it difficult for them to access such exemptions. Overdose deaths declined by nearly 27% in the U.S. from 2023 to 2024, according to data released by the U.S. Centers for Disease Control and Prevention (CDC) in May. That comes out to about 81 lives saved each day, the CDC estimated. The number of overdose deaths specifically involving opioids plummeted from roughly 83,140 in 2023 to 54,743 in 2024, according to the CDC. In a statement, the CDC said the federal government has increased efforts to tackle the issue since Trump declared the opioid epidemic a public health emergency in October 2017, months into his first term. Since Trump returned to office in January, however, his second Administration has proposed sweeping cuts to programs dedicated to addiction treatment and research, while its efforts to address the crisis have focused on combatting drug trafficking from other countries. Many public health and addiction experts have criticized the aggressive strategy, saying that it doesn't effectively address the drug crisis. Linas says to attribute the decline in overdose deaths to cracking down on drug dealers and the border is 'completely false;' instead, he says, the credit should go to bolstering public health measures. The damage the tax and spending package is projected to wreak in opioid treatment, he says, exemplifies broader problems in how the Trump Administration is governing. 'After working so hard and seeing progress, to take such a step back is really depressing,' Linas says. 'It's also a microcosm of the total chaos that this Administration imposes on all of us. Because as recently as a year ago, we were investing a lot of federal dollars to reverse the course of this overdose epidemic and starting to see results, and now we're just going to pick up a 180 and reverse it—it's pretty miserable.'


CNBC
3 hours ago
- CNBC
Kelly Evans: The implosion of the health insurers
It's pretty shocking just how poorly the health insurance names are trading. Centene--a major Obamacare and Medicaid insurer--is down Its stock price after earnings this morning hit 2014 levels. Molina, which is smaller but has higher Medicaid concentration, is down 48%. Humana, which was trading at $550 three years ago, is a $235 stock now. And it doesn't stop there. This comes on top of the higher-profile problems plaguing the country's biggest insurer, UnitedHealth. Those shares are down 56% from their all-time high last November, which came just a month before executive Brian Thompson was shot and killed. Yesterday, the company confirmed it's cooperating with a federal probe into its Medicare billing practices. It might be tempting to dismiss UNH's problems as company-specific, but that wouldn't explain why rival Elevance (formerly Anthem) is also down 29% this month, and 50% below its September all-time high. "This is the worst the Healthcare sector has ever traded," lamented Mizuho strategist Jared Holz, noting this could be the third straight year the sector underperforms the S&P 500 by 20% or more. "JOT," he quipped. "Just Own Tech." So what in the world is going on? Is it just a coincidence that this industry is seeing declines of a magnitude we've rarely seen outside of a financial crisis or market bubble popping? These are hardly overvalued goofball start-ups, memecoins, or overly leveraged financial institutions. They are massive, highly regulated, utility-esque pillars of the U.S. healthcare system. If there is a common thread, it's basically that more people are using their health insurance now, after delaying usage during the pandemic, which made the companies back then appear more profitable than they really were. Add to that federal investigations into profit centers like Medicare and Medicare Advantage. And one expert I recently spoke with even muses that perhaps hospitals are now using AI to get insurance companies to approve and pay for more patient procedures. For Medicaid and Obamacare, you also now have the government pulling back on subsidies and support. The GOP's megabill is expected to "significantly reduce" the number of people on Obamacare next year, per The Wall Street Journal. Hence the massive hit to those insurers this month. Centene shares did reverse higher this morning after the CEO on their earnings call said she believes they will "reprice their marketplace business" for "meaningful margin improvement in 2026." But that, of course, implies price hikes for customers on the other end. And with health insurance costs running nearly triple overall inflation over the past two decades, it's unclear how well that will go over. And yet, how many options do patients who need health coverage really have to turn elsewhere? It is precisely because of their utility-like nature that investor Bill Smead told us on Wednesday he has begun adding UnitedHealth to his U.S. Value Fund. Chris Grisanti of MAI Capital Management has also been a buyer of that name. "The government needs these companies to exist," Smead said on Wednesday, which makes it hard to bet a lot more against them from here. And that's probably true. But to put it differently, as my colleague Brian Sullivan quipped--does that also mean the health insurers, to borrow that dreaded phrase, have now become "too big to fail"? I'll ponder that one while I'm out utilizing their coverage on maternity leave. See you all sometime in roughly mid-November, God willing! Kelly Twitter: @KellyCNBC Instagram: @realkellyevans